Abstract
Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surveillance System, we assessed self-reported HPV vaccine uptake among MSM, using multivariate analysis to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Among 3221 MSM aged 18-26, 157 (4.9%) reported ≥1 vaccine dose. Uptake was higher among men who visited a healthcare provider (aPR 2.3, CI: 1.2-4.2), disclosed same-sex sexual attraction/behavior to a provider (aPR 2.1, CI: 1.3-3.3), reported a positive HIV test (aPR 2.2, CI: 1.5-3.2), or received hepatitis vaccine (aPR 3.9, CI: 2.4-6.4). Of 3064 unvaccinated MSM, 2326 (75.9%) had visited a healthcare provider within 1 year. These national data on HPV vaccine uptake among MSM provide a baseline as vaccination recommendations are implemented.
Original language | English (US) |
---|---|
Pages (from-to) | 6356-6359 |
Number of pages | 4 |
Journal | Vaccine |
Volume | 32 |
Issue number | 48 |
DOIs | |
State | Published - Nov 12 2014 |
Funding
This study was funded by CDC. The authors thank all of the 2011 NHBS participants, Nevin Krishna, Brooke Hoots, and Teresa Finlayson (Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, CDC) for their assistance.
Keywords
- Human papillomavirus (HPV)
- Men who have sex with men (MSM)
- Vaccine uptake
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
- General Immunology and Microbiology
- Infectious Diseases
- Molecular Medicine
- General Veterinary